治疗和预防mopox的新兴药理策略
Douglas W Grosenbach1, Andrew T Russo1, Emily D Blum1
1SIGA Technologies, Inc, Corvallis, OR, USA.
Expert review of clinical pharmacology
|August 18, 2023
概括
马博克斯疫情是通过疫苗和诸如tecovirimat之类的治疗方法来控制的. 改善接种和疫苗覆盖率对于防止未来mopox复苏至关重要. 德科维里马特是一种安全的前线mopox治疗方法.
科学领域:
- * 病毒学和流行病学
- * 传染病药理学 传染病药理学
背景情况:
- * 自2022年5月以来,全球mopox (麻疹) 病例已超过87,000例,死亡人数为119人.
- * 药理干预包括MVA-BN疫苗,tecovirimat,cidofovir,brincidofovir和VIGIV. 这些都是药理干预.
研究的目的:
- * 审查当前的MOPOX治疗和预防措施.
- * 讨论治疗结果,安全性和获取机制.
- * 提供有关MPOX管理策略的专家意见.
主要方法:
- *使用关键词对PubMed进行全面的文献搜索:mopox,麻疹,tecovirimat,brincidofovir,cidofovir,VIGIV,天花疫苗.
- *访问了WHO.int,CDC.gov,FDA.gov和ClinicalTrials.gov的数据,以获得最新的疫情信息.
- *对治疗部署,获取,结果和安全数据的分析.
主要成果:
- *MVA-BN疫苗和可用的治疗方法在很大程度上控制了mopox疫情.
- *Tecovirimat被确定为安全有效的第一线mopox治疗.
- *由于安全问题,Brincidofovir的使用是有限的;VIGIV和cidofovir仅用于严重病例.
结论:
- *加强疫苗的部署和获取对于防止mopox复发至关重要.
- * 德科维里马特 (Tecovirimat) 显示出作为主要治疗选择的前景.
- *建议在严重的mopox感染中使用VIGIV和cidofovir的战略使用.
关键词:
布林西多福维尔 (Brincidofovir) 是一种病毒.在MVA-BN中.ST-246 ST-246 在美国TPOXXXX TPOXXXX 这是一个很大的问题.这就是cidofovir.一个MPOX的MPOX.德科维里马特 (tecovirimat) 是一个接种疫苗免疫球蛋白静脉注射 (VIGIV)更多相关视频
05:38Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
18.0K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.5K
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
272
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
272
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
01:26Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
01:24Parkinson's Disease: Treatment
297
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
297
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
215
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
215